Projects
COVID19 - ONCO-VAC, Vaccination against Covid-19 in cancer patients under active treatment (Belgium, B-VOICE) University of Antwerp
COVID19 – TriVoice PLUS – Astra-Zeneca derde dosis, Vaccination against Covid-19 in cancer: booster shot BNT161b2 vaccine after full vaccination with ChAdOx1-S vaccine (Tri-VOICE plus). University of Antwerp
Prohylaxis of at risks persons with an ultrapotent SARS-CoV-2 neutralizing antibody. KU Leuven
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
which causes COVID-19, has now spread all over the globe, infected
millions, and already killed more than 150.000 people. Elderly people
are most likely to develop severe disease and to die from COVID-19.
The aim of this project is to have a manufacturable, cost-effective,
ultrapotent SARS-CoV-2-neutralizing antibody ready for ...
COVID-19 national surveillance in wastewater: the variants project protocol. University of Antwerp
SARS-CoV-2 prevalence, seroprevalence and seroconversion among healthcare workers in Belgium during the 2020 COVID-19 outbreak Institute of Tropical Medicine
The added value of point-of-care testing in nursing homes during the COVID-19 pandemic KU Leuven
My PhD will mainly focus on the COVID-19 pandemic. At the end of December 2019, several cases of pneumonia of an unknown origin were reported in Wuhan, China. Not long after, they were declared to be caused by the SARS-CoV-2 virus. The virus started to spread quickly and on the 11th of March 2020, the WHO declared the outbreak as a pandemic. The COVID-19 pandemic had a devastated impact in many nursing homes. Numerous nursing homes in Belgium ...
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during one year of the COVID-19 epidemic. University of Antwerp
Development and use of relevant hamster and mouse Sars-Cov-2 infection models to aid the design of therapeutic and prophylactic options for Covid-19. KU Leuven
IIn some patients, COVID-19 progresses from an initially mild viral syndrome to a severe and life-threatening multi-system disorder with cytokine storm. This coronavirus pandemic is putting healthcare systems worldwide under unprecedented and increasing pressure. Efficient vaccines as well antiviral (small molecules and biologicals) and anti-inflammatory drugs are urgently needed. Given the emergency, the repurposing of small molecules and/or ...